Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

10X Genomics Inc (TXG)

  • Business News
  • Jan. 12, 2026, 14:10 UTC
  • 2
  • 1 comments

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Market reaction Comment Full text

TruBridge Inc. (TBRG)

  • Business News
  • Jan. 12, 2026, 14:07 UTC
  • 3
  • 1 comments

TruBridge, Inc.: TruBridge Honored as One of Modern Healthcares Best in Business

Market reaction Comment Full text

Alphatec Holdings Inc (ATEC)

  • Business News
  • Jan. 12, 2026, 14:05 UTC
  • 2
  • 1 comments

ATEC - ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook

Market reaction Comment Full text

TruBridge Inc. (TBRG)

  • Business News
  • Jan. 12, 2026, 14:05 UTC
  • 3
  • 1 comments

TruBridge Honored as One of Modern Healthcares Best in Business

Market reaction Comment Full text

Pacific Biosciences of California Inc (PACB)

  • Business News
  • Jan. 12, 2026, 14:05 UTC
  • 4
  • 1 comments

PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

Market reaction Comment Full text

Pacific Biosciences of California Inc (PACB)

  • Business News
  • Jan. 12, 2026, 14:05 UTC
  • 2
  • 1 comments

PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

Market reaction Comment Full text

10X Genomics Inc (TXG)

  • Business News
  • Jan. 12, 2026, 14:03 UTC
  • 4
  • 1 comments

10x Genomics - Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

Market reaction Comment Full text

Tivic Health Systems Inc. (TIVC)

  • Business News
  • Jan. 12, 2026, 14:02 UTC
  • 6
  • 1 comments

Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug CandidateEntolimod™ And Achieves Reproducible Yields, Potency and Purity

Market reaction Comment Full text

Masimo Corporation (MASI)

  • Business News
  • Jan. 12, 2026, 14:02 UTC
  • 5
  • 1 comments

Masimo - Masimo Announces Select Preliminary 2025 Financial Results

Market reaction Comment Full text

Abcellera Biologics Inc (ABCL)

  • Business News
  • Jan. 12, 2026, 14:01 UTC
  • 4
  • 1 comments

Press Release: AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

Market reaction Comment Full text
  • Previous
  • 83
  • 84
  • 85
  • 86
  • 87
  • Next

Search

News categories

  • Technical Exchange News(10866)
  • Event(2238)
  • SEC News(188879)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124452)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin